These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

311 related items for PubMed ID: 28752048

  • 1. Myeloid protein tyrosine phosphatase 1B (PTP1B) deficiency protects against atherosclerotic plaque formation in the ApoE-/- mouse model of atherosclerosis with alterations in IL10/AMPKα pathway.
    Thompson D, Morrice N, Grant L, Le Sommer S, Ziegler K, Whitfield P, Mody N, Wilson HM, Delibegović M.
    Mol Metab; 2017 Aug; 6(8):845-853. PubMed ID: 28752048
    [Abstract] [Full Text] [Related]

  • 2. Pharmacological inhibition of protein tyrosine phosphatase 1B protects against atherosclerotic plaque formation in the LDLR-/- mouse model of atherosclerosis.
    Thompson D, Morrice N, Grant L, Le Sommer S, Lees EK, Mody N, Wilson HM, Delibegovic M.
    Clin Sci (Lond); 2017 Oct 01; 131(20):2489-2501. PubMed ID: 28899902
    [Abstract] [Full Text] [Related]

  • 3. Myeloid-cell protein tyrosine phosphatase-1B deficiency in mice protects against high-fat diet and lipopolysaccharide-induced inflammation, hyperinsulinemia, and endotoxemia through an IL-10 STAT3-dependent mechanism.
    Grant L, Shearer KD, Czopek A, Lees EK, Owen C, Agouni A, Workman J, Martin-Granados C, Forrester JV, Wilson HM, Mody N, Delibegovic M.
    Diabetes; 2014 Feb 01; 63(2):456-70. PubMed ID: 24186864
    [Abstract] [Full Text] [Related]

  • 4. Myeloid PTP1B deficiency protects against atherosclerosis by improving cholesterol homeostasis through an AMPK-dependent mechanism.
    Oliver H, Ruta D, Thompson D, Kamli-Salino S, Philip S, Wilson HM, Mody N, Delibegovic M.
    J Transl Med; 2023 Oct 12; 21(1):715. PubMed ID: 37828508
    [Abstract] [Full Text] [Related]

  • 5. Adipocyte-specific protein tyrosine phosphatase 1B deletion increases lipogenesis, adipocyte cell size and is a minor regulator of glucose homeostasis.
    Owen C, Czopek A, Agouni A, Grant L, Judson R, Lees EK, Mcilroy GD, Göransson O, Welch A, Bence KK, Kahn BB, Neel BG, Mody N, Delibegović M.
    PLoS One; 2012 Oct 12; 7(2):e32700. PubMed ID: 22389718
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Deleting interleukin-10 from myeloid cells exacerbates atherosclerosis in Apoe-/- mice.
    Orecchioni M, Wolf D, Suryawanshi V, Winkels H, Kobiyama K, Makings J, Kiosses WB, Ley K.
    Cell Mol Life Sci; 2022 Dec 10; 80(1):10. PubMed ID: 36496494
    [Abstract] [Full Text] [Related]

  • 8. Effects of hepatic protein tyrosine phosphatase 1B and methionine restriction on hepatic and whole-body glucose and lipid metabolism in mice.
    Lees EK, Krol E, Shearer K, Mody N, Gettys TW, Delibegovic M.
    Metabolism; 2015 Feb 10; 64(2):305-14. PubMed ID: 25468142
    [Abstract] [Full Text] [Related]

  • 9. Skin-Derived Mesenchymal Stem Cells Alleviate Atherosclerosis via Modulating Macrophage Function.
    Li Q, Sun W, Wang X, Zhang K, Xi W, Gao P.
    Stem Cells Transl Med; 2015 Nov 10; 4(11):1294-301. PubMed ID: 26400926
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Liver-specific deletion of protein-tyrosine phosphatase 1B (PTP1B) improves metabolic syndrome and attenuates diet-induced endoplasmic reticulum stress.
    Delibegovic M, Zimmer D, Kauffman C, Rak K, Hong EG, Cho YR, Kim JK, Kahn BB, Neel BG, Bence KK.
    Diabetes; 2009 Mar 10; 58(3):590-9. PubMed ID: 19074988
    [Abstract] [Full Text] [Related]

  • 12. Pivotal role of protein tyrosine phosphatase 1B (PTP1B) in the macrophage response to pro-inflammatory and anti-inflammatory challenge.
    Través PG, Pardo V, Pimentel-Santillana M, González-Rodríguez Á, Mojena M, Rico D, Montenegro Y, Calés C, Martín-Sanz P, Valverde AM, Boscá L.
    Cell Death Dis; 2014 Mar 13; 5(3):e1125. PubMed ID: 24625984
    [Abstract] [Full Text] [Related]

  • 13. Hepatic protein tyrosine phosphatase 1B (PTP1B) deficiency protects against obesity-induced endothelial dysfunction.
    Agouni A, Tual-Chalot S, Chalopin M, Duluc L, Mody N, Martinez MC, Andriantsitohaina R, Delibegović M.
    Biochem Pharmacol; 2014 Dec 15; 92(4):607-17. PubMed ID: 25451690
    [Abstract] [Full Text] [Related]

  • 14. Lack of mitogen-activated protein kinase phosphatase-1 protects ApoE-null mice against atherosclerosis.
    Shen J, Chandrasekharan UM, Ashraf MZ, Long E, Morton RE, Liu Y, Smith JD, DiCorleto PE.
    Circ Res; 2010 Mar 19; 106(5):902-10. PubMed ID: 20093631
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Myeloid cell-specific Irf5 deficiency stabilizes atherosclerotic plaques in Apoe-/- mice.
    Leipner J, Dederichs TS, von Ehr A, Rauterberg S, Ehlert C, Merz J, Dufner B, Hoppe N, Krebs K, Heidt T, von Zur Muehlen C, Stachon P, Ley K, Wolf D, Zirlik A, Bode C, Hilgendorf I, Härdtner C.
    Mol Metab; 2021 Nov 19; 53():101250. PubMed ID: 33991749
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. The role of protein tyrosine phosphatase 1B (PTP1B) in the pathogenesis of type 2 diabetes mellitus and its complications.
    Teimouri M, Hosseini H, ArabSadeghabadi Z, Babaei-Khorzoughi R, Gorgani-Firuzjaee S, Meshkani R.
    J Physiol Biochem; 2022 May 19; 78(2):307-322. PubMed ID: 34988903
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.